A large-scale shortage of respirators and face shields threatens progress in some labs that are currently trying to ramp up their studies of SARS-CoV-2.

The US lacks standardized methods to assess products for potency and safety. That’s a big problem for the labs tasked with doing the testing.

The agency cites lapses in biosafety procedures at the US Army Medical Research Institute of Infectious Diseases in Maryland.

Recent reports of babies born with opioid withdrawal symptoms after their mothers used kratom during pregnancy have generated much concern about the medicinal herb.

A newly expanded genetic alphabet that includes four synthetic nucleotides highlights the need for strict boundaries on their use.

The agency sends warning letters to makers of products that claim to prevent or treat Alzheimer’s and other diseases, and announces changes to its enforcement practices.

Two professors have been arrested for negligence in connection with the blast.

The European Court of Justice has decided that organisms made with precision techniques such as CRISPR will be subject to the same rules as transgenic plants or animals.

Vanessa Allen Sutherland will resign next month, leaving the agency with just three members of what should be a five-person board.